Nipro Corp.

Nipro and its affiliates are mainly engaged in the manufacture and sale of medical products and glass products. Co. operates in four business segments: medical-related, pharmaceutical-related, pharma packaging and others. Co.'s principal products include injection and infusion-related products, artificial organ-related products, highly functional products, dialysis-related products and diabetic-related products; injectable drug and oral drugs; and glass for glass tube, ampoule, syrings and cartridges. In addition, Co. is engaged in the manufacture and sale of medical products manufacturing machines, the real estate leasing and the non-life insurance agency business.
  • Ticker8086
  • ISINJP3673600007
  • SectorHealth Care Equipment & Services
  • CountryJapan

Analysts

NIPRO CORP. sees an upgrade to Slightly Positive due to a better fundamental star rating

The general evaluation of NIPRO CORP. (JP), a company active in the Medical Equipment industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 3 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date March 22, 2019, the closing price was JPY 1,455.00 and its potential was estimated at JPY 1,637.84.

NIPRO CORP. sees an upgrade to Slightly Positive due to a better fundamental star rating

The general evaluation of NIPRO CORP. (JP), a company active in the Medical Equipment industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 3 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date March 22, 2019, the closing price was JPY 1,455.00 and its potential was estimated at JPY 1,637.84.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch